Artificial intelligence (AI) is moving incredibly fast, and AI agents are already making their way into clinical workflows across major healthcare systems. Healthcare providers are quickly discovering that the speed of AI adoption is outpacing the rigor of proper evaluation. The promise of model context protocol, or MCP, is real. It offers seamless, standards-based data access to the knowledge that AI systems need to act. But in healthcare, “good enough” data isn’t good enough.
The MCP vendor that a health IT organization chooses today will define the quality, safety, and defensibility of their clinical AI for years to come. This article is for the leaders who understand that distinction, and want a framework for making the right call.
You’re a pharmacist verifying a complex medication order for a critically ill patient in an emergency department. Or you’re a physician mid-encounter needing an immediate answer on drug interaction, dosing, or IV compatibility. In the past, that meant toggling between systems with minimal interoperability, hunting through drug monographs, or relying on memory.
Model context protocol changes the architecture. An MCP server gives AI agents a standardized way to reach into trusted data sources or knowledge systems and retrieve exactly what they need, in real-time. This happens without human-initiated lookups, massively easing the administrative burden.
The key word is standardized. MCP creates a common language between AI systems and knowledge sources. But a common language only matters if what’s being said is worth hearing.
The volume and complexity of medical data has outpaced what any individual clinician can hold in working memory. Even with access to multiple clinical decision support tools, finding the right clinical evidence across a variety of tools can take time. Generative AI is moving in to close that gap, and health systems must be ready.
However, a critical distinction is getting lost in the rush to deploy these AI tools. General-purpose AI was not built for patient care. This is why MCP matters. It connects the dots between AI agents and authoritative clinical intelligence, supporting informed decision-making and allowing care teams to work with confidence towards the health outcomes that matter most.
The large language models (LLMs) powering today’s most visible AI-driven tools were trained on broad internet data. Models from companies like Anthropic or Microsoft are incredibly useful for many administrative tasks. While general-purpose AI is useful for many things, it’s not calibrated for the specificity, recency, and clinical nuance that acute care delivery demands.
An AI model that learned drug information from package inserts and Wikipedia is not the same as one drawing from a curated knowledge base meticulously updated daily by clinical pharmacists, nurses, toxicologists, and physician specialists, using a rigorous and unbiased editorial process to maintain accuracy and clinical relevance.
That editorial expertise is not replicable at scale. It is the product of decades of clinical judgment; knowing not just what the literature says, but which studies to trust, how to reconcile conflicting evidence, and how guidance translates to real patients with complex comorbidities, or behavioral health issues. No foundation model has that capability. No amount of fine-tuning produces it. It has to be built and maintained by humans who have spent careers in clinical practice.
This is the gap MCP was made to close. Not by replacing clinical knowledge, but by making evidence-based information accessible to AI systems that would otherwise have to improvise. The question is not whether AI agents will be making medication-related decisions in your health system. The real question is whether those agents will draw from verified clinical intelligence or fill in the gaps themselves.
Multiple vendors are now entering the MCP space, and so the vendor evaluation decision matters enormously. The right knowledge foundation is a durable clinical asset. The wrong one is a liability.
In order to set themselves up for success, healthcare providers need to evaluate vendors with a critical eye. There are some key factors to consider when demanding a higher standard for MCP in healthcare IT.
The foundational credibility argument is simple. The quality of what an AI agent knows determines the quality of what it does.
Data volume is not a proxy for clinical accuracy. Leaders must look for vendors with a documented, human-led clinical review process, rather than basic AI-powered algorithmic curation.
Key questions to ask: Is there an evidence-grading methodology that tells you not just what the data says, but how confident you should be in it and why?
Coverage depth serves as a strategic moat. Clinical AI workflows don’t stay in one domain, and developers who stitch together multiple narrow integrations create fragmentation and inconsistency. Summarized or repackaged data feeds are not sufficient for the highest-acuity clinical environments. A single source that goes deep across drug interactions, drug pricing, IV compatibility, toxicology information and more, provides an undeniable structural advantage.
Key questions to ask: Beyond a wide content footprint, does the vendor offer the specificity and depth clinicians actually need at the point of care? Evaluate vendors on the hardest use cases; the edge cases, the complex patients, the rare interactions, not the straightforward use cases any system can handle.
Expertise plays an indispensable role in patient care. You absolutely need a human in the loop. The consolidated human provenance argument relies on pharmacists, nurses, toxicologists, and other healthcare professionals, rather than raw algorithms. No foundation model has this capability, and no amount of fine-tuning produces it.
Key questions to ask: What happens when a newly published study conflicts with existing guidance? How quickly is that conflict resolved by a clinician, rather than an algorithm?
Regulatory guidance for clinical decision support (CDS) is actively evolving. Health tech developers need a knowledge partner whose content is structured to support compliance, not complicate it. The regulatory landscape will continue to shift around agentic AI in clinical settings, and tools used these environments must be ready.
Key questions to ask: Ask vendors about their flexibility to adapt as healthcare regulation evolves. Is the vendor solution built for clinical longevity rather than technical novelty?
Look for external validation demonstrating that the vendor is an easy partner to work with for MCP clients. The developer experience, a clean, flexible framework, and seamless integration must be considered. A fast, well-documented API can make all the difference for rapid scalability.
Key questions to ask: Can the vendor provide external evidence of the experience they provide as a partner? Will they let you speak to their clients about the ease of integration they offer?
Security and privacy guardrails remain non-negotiable when dealing with patient data, PHI, and HIPAA requirements. Any MCP implementation must strictly enforce permissions and data access controls, ensuring that generative AI outputs never compromise patient privacy while operating seamlessly within secure healthcare systems and the broader healthcare data ecosystem. A commitment to protecting privacy must include active mitigation of any vulnerability introduced through technology or process.
Technology will inevitably change over time. The fundamental need for accessing and sharing reliable data in healthcare will not. This space is moving incredibly fast, and healthcare providers must stay well-informed to take decisive action and demand excellence from clinical AI.
Micromedex is opening a limited early access program for health technology partners ready to build on the knowledge layer that acute care has trusted for over 50 years. This is not a feature announcement. It’s an invitation to define what healthcare AI should look like in real-world use.
Contact us today to partner on this path of innovation.